New study Finds EPA and DHA omega-3S lower risk of coronary heart disease

摘要

EPA and DHA omega-3s reduce the risk of coronary heart disease (CHD), according to results of a new, comprehensive meta-analysis published in the Mayo Clinic Proceedings and sponsored by the Global Organization for EPA and DHA Omega-3s (COED). Among randomized controlled trials (RCTs), there was a statistically significant reduction in CHD risk in higher risk populations, including: 1. 16% in those with high triglycerides and 14% in those with high LDL cholesterol. 2. A non-statistically significant 6 percent risk reduction among all populations in RCTs, a finding supported by a statistically significant 18% reduced risk of CHD among prospective cohort studies.